Vitamin Shoppe Inc (VSI) was Initiated by Wedbush to “Outperform” and the brokerage firm has set the Price Target at $39. Wedbush advised their investors in a research report released on Apr 21, 2016.
On the company’s financial health, Vitamin Shoppe Inc reported $0.39 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Feb 23, 2016. Analyst had a consensus of $0.38. The company had revenue of $293.50 million for the quarter, compared to analysts expectations of $293.70 million. The company’s revenue was up 1.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.41 EPS.
Vitamin Shoppe Inc closed down -0.31 points or -1.04% at $29.44 with 1,20,171 shares getting traded on Monday. Post opening the session at $29.62, the shares hit an intraday low of $29.08 and an intraday high of $29.62 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
In a different news, on Aug 18, 2015, B. Michael Becker (director) sold 845 shares at $36.74 per share price. According to the SEC, on May 26, 2015, Colin Frederick Watts (CEO) purchased 2,400 shares at $41.02 per share price.
Vitamin Shoppe Inc. (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins minerals herbs specialty supplements sports nutrition and other health and wellness products (VMS). The Company operates through three segments: retail which includes Vitamin Shoppe Super Supplements and Vitapath retail store formats; direct which consists of its e-commerce and catalog formats and manufacturing which consists of the Nutri-Force manufacturing operations. The Company operates through its wholly owned subsidiary Vitamin Shoppe Industries Inc. and Vitamin Shoppe Industries Inc.s’ wholly owned subsidiaries VS Direct Inc. Vitamin Shoppe Mariner Inc. (VSM) VS Hercules LLC (VSH) Vitamin Shoppe Global Inc. (VSG) and Vitapath Canada Limited (VCL).